【Healthkoreanews】The U.S. court of Appeals for the federal Circuit kicked claims submitted by Apotex in a patent lawsuit against sanofi-aventis and bristol-Myers Squibb over its Plavix.
sanofi-aventis and bristol-Myers Squibb announced on Dec. 13 that The U.S. court of Appeals for the federal Circuit has upheld the June 19. 2007 decision by the U.S. District court for the southern District of New York holding the U.S. patent 4847265 covering clopidogrel bisulphate, the active ingredient in Plavix, valid and enforceable.
As result of this ruling, the 265 patent protection for this product is maintained in the U.S.until November 2011.<헬스코리아뉴스>